Evidence map›Paper›PMID 31119368›Full record

ArticleVirchows Archiv : an international journal of pathology2019

Transient receptor potential vanilloid (TRPV) channel expression in meningiomas: prognostic and predictive significance.

Spyridoula Goutsou, Chrisi Tsakona, Afroditi Polia, Athanasia Moutafidi, Vassiliki Zolota, George Gatzounis, Martha Assimakopoulou

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Virchows Archiv : an international journal of pathology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. The role of TRPV4 in programmed cell deaths.Molecular biology reports · 2024
    Review
  4. Article
  5. Article
  6. The TRPV2 cation channels: from urothelial cancer invasiveness to glioblastoma multiforme interactome signature.Laboratory investigation; a journal of technical methods and pathology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Spyridoula GoutsouDepartment of Anatomy, Histology and Embryology, School of Medicine, University of Patras, Biomedical Sciences Research Building, 1 Asklipiou, 265 04, Rion, Greece.
Chrisi TsakonaDepartment of Anatomy, Histology and Embryology, School of Medicine, University of Patras, Biomedical Sciences Research Building, 1 Asklipiou, 265 04, Rion, Greece.
Afroditi PoliaDepartment of Anatomy, Histology and Embryology, School of Medicine, University of Patras, Biomedical Sciences Research Building, 1 Asklipiou, 265 04, Rion, Greece.
Athanasia MoutafidiDepartment of Anatomy, Histology and Embryology, School of Medicine, University of Patras, Biomedical Sciences Research Building, 1 Asklipiou, 265 04, Rion, Greece.
Vassiliki ZolotaDepartment of Pathology, University Hospital of Patras, 265 04, Rion, Greece.
George GatzounisDepartment of Neurosurgery, University Hospital of Patras, 265 04, Rion, Greece.
Martha AssimakopoulouDepartment of Anatomy, Histology and Embryology, School of Medicine, University of Patras, Biomedical Sciences Research Building, 1 Asklipiou, 265 04, Rion, Greece. massim@upatras.gr.ORCID http://orcid.org/0000-0002-8990-4000
University of Patras · GRGeneral University Hospital of Patras · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The TRPV1-4 members of TRPV cation channel subfamily are mainly regarded as polymodal receptors that may be activated by diverse changes in cellular microenvironment and endogenous and exogenous agents. Abnormal expression of these channels has been reported in various tumors but not in meningiomas. Meningioma cells are thought to originate from arachnoid cap cells due to cytological and functional similarities between the two types of cells. To investigate the expression profile of TRPV1-4 channels in meningiomas and compare with TRPV1-4 channel expression in leptomeninges, we used immunohistochemistry in formalin-fixed, paraffin-embedded semi-serial tissue sections from 175 meningiomas with different grades and histological subtypes, and normal brain or meningioma specimens that contained leptomeninges. The labeling index (LI), defined as the percentage of positive (labeled) cells out of the total number of tumor cells counted, was determined. Leptomeninges were TRPV1-4 immunonegative. A significant percentage of tumors exhibited TRPV1-4 channel expression which was independent of the proliferation index of the tumors but was significantly associated with histopathological subtypes. The TRPV1 and TRPV3 immunoexpression was decreased whereas TRPV4 immunoexpression was significantly greater in high-grade (WHO, grade II and III) as compared with low-grade (WHO, grade I) meningiomas. Additionally, TRPV4 emerged as an independent predictor for the degree of malignancy using the binary logistic regression model [dependent variable: grade I versus higher grades (II and III)]. Kaplan-Meier analysis for 102 patients showed no significant association of TRPV1-4 expression with overall survival. The above data support that TRPV1-4 channels are implicated in meningioma pathogenesis, and TRPV4 has predictive significance in the disease.

Indexed as

AdultAgedAged, 80 and overCell ProliferationFemaleHumansImmunohistochemistryMaleMeningeal NeoplasmsMeningiomaMiddle AgedNeoplasm GradingPredictive Value of TestsTRPV Cation ChannelsYoung AdultTRPV1 protein, humanTRPV2 protein, humanTRPV3 protein, humanTRPV4 protein, humanTRPV Cation ChannelsMeningiomasTRPV1TRPV2TRPV3TRPV4

Identifiers

PMID31119368
OpenAlexW2945313755

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.